Objectives: To evaluate the influence of vancomycin dose, serum trough concentration, and dosing strategy on the evolution of acute kidney injury in critically ill patients
Background: There is enough evidence to suggest that vancomycin increases the risk of acute kidney i...
To obtain pharmacokinetic and pharmacodynamic data for vancomycin in a cohort of critically ill pedi...
BACKGROUND:To determine the association of vancomycin with acute kidney injury (AKI) in relation to ...
Vancomycin is a glycopeptide antibiotic commonly used in the management of methicillin-resistant Sta...
For vancomycin therapy of severe infections, the Infectious Diseases Society of America recommends h...
IntroductionVancomycin is widely used to treat infections caused by Gram positive bacteria, mostly m...
The impact of serum concentrations of vancomycin is a controversial topic. Results: 182 critically i...
Background: The advocated pharmacokinetic/pharmacodynamic (PK/PD) target for vancomycin, AUC/MIC≥400...
In recent times the use of larger doses of vancomycin aimed at curbing the increasing incidence of r...
Few data are available on the occurrence of renal failure during continuous infusion of vancomycin i...
SummaryObjectiveTo identify specific risk factors of vancomycin-induced nephrotoxicity in China, as ...
Vancomycin is a key tool in the treatment of serious Gram-positive infections. A progressive increas...
Several single-center studies have suggested that higher doses of vancomycin, aimed at producing tro...
Vancomycin is the most frequently used antibiotic, accounting for up to 35% of hospitalized patients...
Background: Vancomycin is a cornerstone antibiotic for the management of severe Gram positive infect...
Background: There is enough evidence to suggest that vancomycin increases the risk of acute kidney i...
To obtain pharmacokinetic and pharmacodynamic data for vancomycin in a cohort of critically ill pedi...
BACKGROUND:To determine the association of vancomycin with acute kidney injury (AKI) in relation to ...
Vancomycin is a glycopeptide antibiotic commonly used in the management of methicillin-resistant Sta...
For vancomycin therapy of severe infections, the Infectious Diseases Society of America recommends h...
IntroductionVancomycin is widely used to treat infections caused by Gram positive bacteria, mostly m...
The impact of serum concentrations of vancomycin is a controversial topic. Results: 182 critically i...
Background: The advocated pharmacokinetic/pharmacodynamic (PK/PD) target for vancomycin, AUC/MIC≥400...
In recent times the use of larger doses of vancomycin aimed at curbing the increasing incidence of r...
Few data are available on the occurrence of renal failure during continuous infusion of vancomycin i...
SummaryObjectiveTo identify specific risk factors of vancomycin-induced nephrotoxicity in China, as ...
Vancomycin is a key tool in the treatment of serious Gram-positive infections. A progressive increas...
Several single-center studies have suggested that higher doses of vancomycin, aimed at producing tro...
Vancomycin is the most frequently used antibiotic, accounting for up to 35% of hospitalized patients...
Background: Vancomycin is a cornerstone antibiotic for the management of severe Gram positive infect...
Background: There is enough evidence to suggest that vancomycin increases the risk of acute kidney i...
To obtain pharmacokinetic and pharmacodynamic data for vancomycin in a cohort of critically ill pedi...
BACKGROUND:To determine the association of vancomycin with acute kidney injury (AKI) in relation to ...